Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT: Celecoxib in primary breast cancer
NCT02429427Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Dec 2005
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of celecoxib in breast cancer, sponsored by Imperial College London. Started Dec 2005; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02429427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429427.